Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology

Oral Oncol. 2020 Aug:107:104813. doi: 10.1016/j.oraloncology.2020.104813. Epub 2020 May 21.

Abstract

  1. Screening is imperative to safeguard patients, practitioners and staff.

  2. Various tests available for screening and diagnosing patients for SARS-CoV-2.

  3. Rapid test can be used to screen patients before any surgical intervention.

  4. Along with testing, clinical features should be corroborated.

  5. Oral findings might aid in early diagnosis of COVID-19.

Publication types

  • Letter

MeSH terms

  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • Betacoronavirus / genetics
  • Betacoronavirus / immunology
  • Betacoronavirus / isolation & purification*
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques / methods
  • Clinical Laboratory Techniques / standards*
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / transmission
  • Coronavirus Infections / virology
  • Early Diagnosis
  • Gingival Crevicular Fluid / immunology
  • Gingival Crevicular Fluid / virology
  • Head and Neck Neoplasms / surgery*
  • Health Personnel / standards
  • Humans
  • Infection Control / instrumentation
  • Infection Control / standards
  • Infectious Disease Transmission, Patient-to-Professional / prevention & control
  • Infectious Disease Transmission, Professional-to-Patient / prevention & control
  • Mass Screening / methods
  • Mass Screening / standards
  • Otorhinolaryngologic Surgical Procedures / standards
  • Pandemics / prevention & control*
  • Personal Protective Equipment / standards
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / transmission
  • Pneumonia, Viral / virology
  • RNA, Viral / isolation & purification
  • SARS-CoV-2
  • Saliva / immunology
  • Saliva / virology
  • Surgical Oncology / standards*

Substances

  • Antibodies, Viral
  • RNA, Viral